FR2819513B1 - Nouveaux derives du mikanolide, leur preparation et leurs applications therapeutiques - Google Patents

Nouveaux derives du mikanolide, leur preparation et leurs applications therapeutiques

Info

Publication number
FR2819513B1
FR2819513B1 FR0100397A FR0100397A FR2819513B1 FR 2819513 B1 FR2819513 B1 FR 2819513B1 FR 0100397 A FR0100397 A FR 0100397A FR 0100397 A FR0100397 A FR 0100397A FR 2819513 B1 FR2819513 B1 FR 2819513B1
Authority
FR
France
Prior art keywords
novel
preparation
therapeutic applications
mikanolide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0100397A
Other languages
English (en)
Other versions
FR2819513A1 (fr
Inventor
Olivier Lavergne
Christophe Lanco
Gregoire Prevost
Beng Poon Teng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to FR0100397A priority Critical patent/FR2819513B1/fr
Priority to TW090132164A priority patent/TWI293302B/zh
Priority to MYPI20015945A priority patent/MY130454A/en
Priority to HU0303873A priority patent/HUP0303873A3/hu
Priority to AU2002229870A priority patent/AU2002229870B2/en
Priority to CNB02803614XA priority patent/CN1234711C/zh
Priority to RU2003124760/04A priority patent/RU2278121C2/ru
Priority to NZ526690A priority patent/NZ526690A/en
Priority to ARP020100095A priority patent/AR035681A1/es
Priority to CZ20032167A priority patent/CZ20032167A3/cs
Priority to AT02710969T priority patent/ATE319716T1/de
Priority to US10/250,383 priority patent/US6887869B2/en
Priority to ES02710969T priority patent/ES2260417T3/es
Priority to CA002433981A priority patent/CA2433981A1/fr
Priority to PL02365342A priority patent/PL365342A1/xx
Priority to JP2002556192A priority patent/JP4418627B2/ja
Priority to KR1020037009279A priority patent/KR100859227B1/ko
Priority to MXPA03006162A priority patent/MXPA03006162A/es
Priority to PCT/FR2002/000092 priority patent/WO2002055523A1/fr
Priority to DE60209698T priority patent/DE60209698T2/de
Priority to IL15659302A priority patent/IL156593A0/xx
Priority to BR0206311-5A priority patent/BR0206311A/pt
Priority to EP02710969A priority patent/EP1353926B1/fr
Publication of FR2819513A1 publication Critical patent/FR2819513A1/fr
Priority to NO20033118A priority patent/NO20033118L/no
Priority to ZA200305313A priority patent/ZA200305313B/en
Priority to HK04106637A priority patent/HK1063793A1/xx
Application granted granted Critical
Publication of FR2819513B1 publication Critical patent/FR2819513B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FR0100397A 2001-01-12 2001-01-12 Nouveaux derives du mikanolide, leur preparation et leurs applications therapeutiques Expired - Fee Related FR2819513B1 (fr)

Priority Applications (26)

Application Number Priority Date Filing Date Title
FR0100397A FR2819513B1 (fr) 2001-01-12 2001-01-12 Nouveaux derives du mikanolide, leur preparation et leurs applications therapeutiques
TW090132164A TWI293302B (en) 2001-01-12 2001-12-25 New derivatives of mikanolide, their preparation and their therapeutic uses
MYPI20015945A MY130454A (en) 2001-01-12 2001-12-31 Mikanolide derivatives, their preparation and therapeutic uses
KR1020037009279A KR100859227B1 (ko) 2001-01-12 2002-01-11 미카놀리드의 유도체, 그의 제조 및 그의 치료상 용도
CNB02803614XA CN1234711C (zh) 2001-01-12 2002-01-11 薇甘菊内酯衍生物,其制备方法及其治疗用途
RU2003124760/04A RU2278121C2 (ru) 2001-01-12 2002-01-11 Производные миканолида, фармацевтическая композиция на их основе и их применение
NZ526690A NZ526690A (en) 2001-01-12 2002-01-11 Mikanolide derivatives, their preparation and therapeutic uses
ARP020100095A AR035681A1 (es) 2001-01-12 2002-01-11 Derivados de mikanolida, composicion farmaceutica, medicamento y uso en la preparacion de un medicamento
CZ20032167A CZ20032167A3 (en) 2001-01-12 2002-01-11 Mikanolide derivatives, their preparation and therapeutic uses
AT02710969T ATE319716T1 (de) 2001-01-12 2002-01-11 Mikanolid-derivate, ihre herstellung und ihr gebrauch für therapeutische anwendungen
US10/250,383 US6887869B2 (en) 2001-01-12 2002-01-11 Mikanolide derivatives, their preparation and therapeutic uses
ES02710969T ES2260417T3 (es) 2001-01-12 2002-01-11 Derivados de mikanolida, su preparacion y sus aplicaciones terapeuticas.
CA002433981A CA2433981A1 (fr) 2001-01-12 2002-01-11 Derives du mikanolide, leur preparation et leurs applications therapeutiques
PL02365342A PL365342A1 (en) 2001-01-12 2002-01-11 Mikanolide derivatives, their preparation and therapeutic uses
HU0303873A HUP0303873A3 (en) 2001-01-12 2002-01-11 Mikanolide derivatives, process for their preparation and their therapeutic uses as a medicine
AU2002229870A AU2002229870B2 (en) 2001-01-12 2002-01-11 Mikanolide derivatives, their preparation and therapeutic uses
MXPA03006162A MXPA03006162A (es) 2001-01-12 2002-01-11 Derivados de mikanolida, su preparacion y sus usos terapeuticos.
PCT/FR2002/000092 WO2002055523A1 (fr) 2001-01-12 2002-01-11 Derives du mikanolide, leur preparation et leurs applications therapeutiques
DE60209698T DE60209698T2 (de) 2001-01-12 2002-01-11 Mikanolid-derivate, ihre herstellung und ihr gebrauch für therapeutische anwendungen
IL15659302A IL156593A0 (en) 2001-01-12 2002-01-11 Mikanolide derivatives, their preparation and therapeutic uses
BR0206311-5A BR0206311A (pt) 2001-01-12 2002-01-11 Composto, composição farmacêutica, e, utilização de um composto
EP02710969A EP1353926B1 (fr) 2001-01-12 2002-01-11 Derives de mikanolide, leur preparation et leurs applications therapeutiques
JP2002556192A JP4418627B2 (ja) 2001-01-12 2002-01-11 ミカノリド誘導体、その製造及びその医療用途
NO20033118A NO20033118L (no) 2001-01-12 2003-07-08 Mikanolide-derivater, farmasoytiske preparater inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdom
ZA200305313A ZA200305313B (en) 2001-01-12 2003-07-09 Mikanolide derivatives, their preparation and therapeutic uses.
HK04106637A HK1063793A1 (en) 2001-01-12 2004-09-03 Mikanolide derivatives, their preparation and therapeutic uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0100397A FR2819513B1 (fr) 2001-01-12 2001-01-12 Nouveaux derives du mikanolide, leur preparation et leurs applications therapeutiques

Publications (2)

Publication Number Publication Date
FR2819513A1 FR2819513A1 (fr) 2002-07-19
FR2819513B1 true FR2819513B1 (fr) 2005-06-17

Family

ID=8858748

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0100397A Expired - Fee Related FR2819513B1 (fr) 2001-01-12 2001-01-12 Nouveaux derives du mikanolide, leur preparation et leurs applications therapeutiques

Country Status (6)

Country Link
FR (1) FR2819513B1 (fr)
HK (1) HK1063793A1 (fr)
HU (1) HUP0303873A3 (fr)
IL (1) IL156593A0 (fr)
NO (1) NO20033118L (fr)
ZA (1) ZA200305313B (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801792B1 (fr) * 1999-12-01 2003-04-18 Sod Conseils Rech Applic Un nouveau medicament, le dihydromikanolide, son obtention par extraction de la plante mikania micrantha et son utilisation comme agent anti-proliferatif

Also Published As

Publication number Publication date
FR2819513A1 (fr) 2002-07-19
NO20033118L (no) 2003-07-11
ZA200305313B (en) 2004-06-14
HUP0303873A2 (hu) 2004-03-29
NO20033118D0 (no) 2003-07-08
IL156593A0 (en) 2004-01-04
HUP0303873A3 (en) 2005-02-28
HK1063793A1 (en) 2005-01-14

Similar Documents

Publication Publication Date Title
MA27049A1 (fr) Derives de 1-phenylsulfonyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique
FR2835528B1 (fr) Nouveaux derives peptidiques, leur preparation et leur application therapeutique et cosmetique
FR2854158B1 (fr) Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique
FR2864080B1 (fr) Derives de 1-piperazine-et-1-homopiperazine-carboxylates, leur preparation et leur application en therapeutique
NO20033143L (no) Farmasoytisk preparat
FR2843964B1 (fr) Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
FR2854633B1 (fr) Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique
DK1453517T3 (da) Farmaceutiske formuleringer med platinderivat
EE200300416A (et) Ravimvorm
FR2873691B1 (fr) Derives d'amino-piperidine, leur preparation et leur application en therapeutique
FR2850377B1 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
MA27233A1 (fr) Derives de piperazinylacylpiperidine, leur preparation et leur application en therapeutique
FR2856684B1 (fr) Derives de diphenylpyridine, leur preparation et leur application en therapeutique
NO20033737L (no) PEG-konjugater av HGT-NK4
FR2786482B1 (fr) Nouveaux derives de 2-pyridone, leur preparation et leur application en therapeutique
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
FR2809731B1 (fr) Derives de 1,4-diazabicyclo-[3.2.2] nonane-pheylisoxazole, leur preparation et leur application en therapeutique
FR2837824B1 (fr) Nouveaux derives de la podophyllotoxine, leur preparation et leur application en therapeutique
FR2873690B1 (fr) Derives d'oxopiperidine, leur preparation et leur application en therapeutique
NO20025805L (no) Farmasöytisk preparat
FR2842808B1 (fr) Nouveaux derives d'arylimidazoles, leur preparation et leurs applications therapeutiques
NO20042693L (no) Kateterpreparat og anvendelser derav
FR2873693B1 (fr) Derives d'amino-tropane, leur preparation et leur application en therapeutique
NO20033120D0 (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
FR2862967B1 (fr) Derives de (4-phenylpiperazin-1-yl)acylpiperidine, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
ST Notification of lapse

Effective date: 20100930